Business
Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial
Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial

About this update from Imugene Ltd
[{"type":"text","content":"Imugene Ltd has released a press release. View Attachment","length":216,"tagName":"div"}]